Progress, in the clinical and molecular genetics of familial parkinsonism

Neurogenetics

Volumn 2, Issue 4, 2000, Pages 207-218

  Kitada, Tohru ^a   Asakawa, Shuichi ^b   Matsumine, Hiroto ^a   Hattori, Nobutaka ^a   Shimura, Hideki ^a   Minoshima, Shinsei ^b   Shimizu, Nobuyoshi ^b   Mizuno, Yoshikuni ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Familial Parkinson's disease; Genetics; Parkin; Parkinson's disease; Synuclein

Indexed keywords

ALPHA SYNUCLEIN;

CHROMOSOME 2P; CLINICAL FEATURE; GENETIC RISK; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; MOLECULAR GENETICS; PARKINSONISM; POINT MUTATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0034075656     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100489900083     Document Type: Review

References (106)

1. Parkinson J (1817) An essay on the shaking palsy. Whittingham and Rowland, London
2. Schapira AH (1995) Nuclear and mitochondrial genetics in Parkinson's disease. J Med Genet 32:411-414
3. Kusumi M, Nakashima K, Harada H, Takahashi K, Nakayama H (1994) Epidemiology of Parkinson's disease in Yonago city (abstract). Jpn Mov Disord 9 [Suppl 1]:95
4. De Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, Van der Meche FGA, Hofman A (1995) Prevalence of Parkinson's disease in the elderly: the Rotterdam study. Neurology 45:2143-2146
5. Wood N (1997) Genes and parkinsonism. J Neurol Neurosurg Psychiatry 62:305-309
6. Gasser T (1998) Genetics of Parkinson's disease. Ann Neurol [Suppl 1] 44:S53-S57
7. Riess O, Jakes R, Kruger R (1998) Genetic dissection of familial Parkinson's disease. Mol Med Today 4:438-444
8. Jenner P, Schapira AHV, Marsden CD (1992) New insights into the cause of Parkinson's disease. Neurology 42:2241-2250
9. Schapira AH (1996) Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr Opin Neurol 9:260-264
10. Mizuno Y, Yoshino H, Hattori N, Kobayashi T, Shimoda-Matsubayashi S, Matsumine H, Kondo T (1998) Mitoehondrial dysfunction in Parkinson's disease. Ann Neurol 44:99-109
11. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
12. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadcu A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047
13. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608
14. Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of Lewy body. J Neuropathol Exp Neurol 52:183-191
15. Lennox G, Lowe J, Landon M, Mayer RJ (1989) Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 52:67-71
16. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:839-840
17. Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC (1996) Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274:1197-1199
18. Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC (1990) A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 27:276-282
19. Golbe LI, Di Iorio G, Sanges G, Lazzarini AM, La Sala S, Bonavita V, Duvoisin RC (1996) Clinical genetic analysis of Parkinson's disease in Contursi kindred. Ann Neurol 40:767-775
20. Chen X, De Silva HA, Pettenati MJ, Rao PN, St. George-Hyslop P, Roses AD, Xia Y, Horsburgh K, Ueda K, Saitoh T (1995) The human NACP/α -synuclein gene: chromosome assignment to 4q21.3-q22 and Taq I RFLP analysis. Genomics 26:425-427
21. Kruger T, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 18:106-108
22. Farrer M, Wavrant-De Vrieze F, Crook R, Boles L, Perez-Tur J, Hardy J, Johnson WG, Steele J, Maraganore D, Gwinn K, Lynch T (1998) Low frequency of α-synuclein mutations in familial Parkinson's disease. Ann Neurol 43:394-397
23. Zareparsi S, Kay J, Camicioli R, Kramer P, Nutt J, Bird T, Litt M, Payami H (1998) Analysis of the α-synuclein G209A mutation in familial Parkinson's disease. Lancet 351:37-38
24. Vaughan JR, Farrer MJ, Wszolek ZW, Gasser T, Durr A, Agid Y, Bonifati V, DeMichele G, Volpe G, Lincoln S, Breteler M, Meco G, Brice A, Marsden CD, Hardy J, Wood NW (1998) Sequencing of the a-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. Hum Mol Genet 7:751-753
25. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879-884
26. Trojanowski JQ, Lee VMY (1998) Aggregation of neurofilament and α-synuclein proteins in Lewy bodies. Arch Neurol 55:151-152
27. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 95:6469-6473
28. Arima K, Uéda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka Uehara H, Kawai M (1998) Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808:93-100
29. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc Nail Acad Sci U S A 90:11282-11286
30. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251:205-208
31. El-Agnaf OM, Jakes R, Curran MD, Middleton D, Ingenito R, Bianchi E, Pessi A, Neill D, Wallace A ( 1998) Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments. FEBS Lett 440:71-75
32. Conway K, Harper JD, Lansbury PT (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson's disease. Nat Med 4:1318-1320
33. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, Silva HA de, Kittel A, Saitoh T (1995) The precursor protein of non-A β component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467-475
34. Buchman VL, Hunter HJA, Pinon LGP, Thompson J, Privalova EM, Ninkina NN, Davies AM (1998) Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. J Neurosci 18:9335-9341
35. Clayton DF, George JM (1998) The synuclein: a family of proteins involved in synaptic function, plasticity, neurode-generation and disease. Trends Neurosci 21:249-254
36. George JM, Jin H, Woods WS, Clayton DF (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361-372
37. Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443-9449
38. Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M (1998) Binding of α-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 273:26292-26294
39. Gasser T, Muller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB, Bonifati V, Bereznai B, Fabrizio E, Vieregge P, Horstmann RD (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 18:262-265
40. Wszolek ZK, Cordes M, Calne DB, Munter MD, Cordes I, Pfeiffer RF (1993) Hereditary Parkinson's disease: report of 3 families with dominant autosomal inheritance. Nervenarzt 64:331-335
41. Wszolek ZK, Pfeiffer B, Fulgham JR, Parisi JE, Thompson BM, Uitti RJ, Calne DB, Pfeiffer RF (1995) Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 45:502-505
42. Denson MA, Wszolek ZK (1995) Familial parkinsonism: our experience and a review of literature. Parkinsonism Relat Disord 1:1-8
43. Denson MA, Wszolck ZK, Pfeiffer RF, Wszolek EK, Paschall TM, McComb RD (1997) Familial parkinsonism, dementia, and Lewy body disease: study of family G. Ann Neurol 42:638-643
44. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH (1998) The ubiquitin pathway in Parkinson's disease. Nature 395:451-452
45. Larsen CN, Krantz BA, Wilkinson KD (1998) Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolase. Biochemistry 37:3358-3368
46. Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson KD (1990) Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161:153-160
47. Stacy M, Jankovic J (1992) Differential diagnosis of Parkinson's disease and parkinsonism plus syndromes. Neurol Clin 10:341-359
48. Cohen S, Freedman M (1995) Cognitive and behavioral changes in the Parkinson-plus syndromes. Adv Neurol 65:139-157
49. Farrer M, Gwinn-Hardy K, Muenter M, De Vrieze FW, Crook R, Perez-Tur J, Lincoln S, Maraganore D, Adler C, Newman S, MacElwee K, McCarthy P, Miller C, Waters C, Hardy J (1999) A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 8:81-85
50. Hardy J, Perez-Tur J, Baker M, Farrer M, Crook R, Hutton M, Johnson WG, Gwinn K, Muenter M, Rocca WA, Maraganore D (1998) Exclusion of genetic linkage to 4q21-23 and 17q21 in a family with Lewy body parkinsonism. Am J Med Genet 81:166-171
51. Muenter MD, Howard FM, Okazaki H, Forno LS, Kish SJ, Hornykiewicz O (1986) A familial parkinsonism-dementia syndrome. Neurology [Suppl] 36:115
52. Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ, Okazaki H, Howard FM, Snow BJ, Calne DB (1997) Hereditary form of parkinsonism-dementia. Ann Neurol 43:768-781
53. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, D'Souza I, Lee VM, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC (1998) Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A 95:13103-13107
54. Wijker M, Wszolek ZK, Wolters EC, Rooimans MA, Pals G, Pfeiffer RF, Lynch T, Rodnitzky RL, Wilhelmsen KC, Arwert F (1996) Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. Hum Mol Genet 5:151-154
55. Wilhelmsen KC (1997) Disinhibition-dementia-parkinsonism-amyotrophy complex (DDPAC) is a non-Alzheimer's frontotemporal dementia. J Neural Transm [Suppl] 49:269-275
56. Wilhelmsen KC, Lynch T, Pavlou E, Higgins M, Nygaard TG (1994) Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 55:1159-1165
57. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43:815-825
58. Muller U, Steinberger D, Nemeth AH (1998) Clinical and molecular genetics of primary dystonias. Neurogenetics 1:165-177
59. Fahn S, Moskowitz C (1988) X-linked recessive dystonia and parkinsonism in Filipino males (abstract). Ann Neurol 24:179
60. Lee LV, Pascasio FM, Fuentes FD, Viterbo GH (1976) Torsion dystonia in Panay, Philippines. Adv Neurol 14:137-151
61. Lee LV, Kupke KG, Caballar-Conzaga F, Hebron-Ortiz M, Muller U (1991) The phenotype of the X-linked dystoniaparkinsonism syndrome. An assessment of 42 cases in the Philippines. Medicine (Baltimore) 70:179-187
62. Walters CH, Faust PL, Powers J, Vinters H, Moskowitz C, Nygaard T, Hunt AL, Fahn S (1993) Neuropathology of lubag (X-linked dystonia parkinsonism). Mov Disord 8:387-390
63. Haberhausen G, Schmitt I, Kohler A, Peters U, Rider S, Chelly J, Tewilliger J D, Monaco AP, Muller U (1995) Assignment of the dystonia-parkinsonism syndrome locus, DYT3, to a small region within a 1.8-Mb YAC contig of Xq13.1. Am J Hum Genet 57:644-650
64. Yamamura Y, Sobue I, Ando K, Iida M, Yanagi T (1973) Paralysis agitans of early onset with marked diurnal fluctuation of symptoms. Neurology 23:239-244
65. Yamamura Y, Arihiro K, Kohriyama T, Nakamura S (1993) Early-onset parkinsonism with diurnal fluctuation: clinical and pathological studies. Rinsho Shinkeigaku 33:491-496
66. Yamamura Y, Kohriyama T, Kawakami H, Kaseda Y, Kuzuhara S, Nakamura S (1996) Autosomal recessive early-onset parkinsonism with diurnal fluctuation (AR-EPDF) - clinical characteristics. Clin Neurol (Tokyo) 36:944-950
67. Takahashi H, Ohama E, Suzuki S, Horikawa Y, Ishikawa A, Morita T, Tsuji S, Ikuta F (1994) Familial parkinsonism: clinical and pathologic study in a family. Neurology 44:437-441
68. Yamamura Y, Kohriyama T, Kaseda Y, Nakamura S (1994) Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathological characteristics and nosological identification. Rinsho Shinkeigaku 41:231-238
69. Matsumine H, Yamamura Y, Kobayashi T, Nakamura S, Kuzuhara S, Mizuno Y (1998) Early onset parkinsonism with diurnal fluctuation maps to a locus for juvenile parkinsonism. Neurology 50:1340-1345
70. Ishikawa A, Tsuji S (1996) Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 47:160-169
71. Matsumine H, Saito M, Shimoda-Matsubayashi S, Tanaka H, Ishikawa A, Hattori Y, Yokochi M, Kobayashi T, Igarashi S, Takano H, Sanpei K, Koike R, Mori H, Kondo T, Mizutani Y, Schaffer AA, Yamamura Y, Nakamura S, Kuzuhara S, Tsuji S, Mizuno Y (1997) Localization of a gene for an autosomal recessive form of juvenile parkinsonism to chromosome 6q25.2-27. Am J Hum Genet 60:588-596
72. Matsumine H, Yamamura Y, Hattori N, Kobayashi T, Kitada T, Yoritaka A, Mizuno Y (1998) A microdeletion of D6S305 in a family of autosomal recessive juvenile parkinsonism (PARK 2). Genomics 49:143-146
73. Asakawa S, Abe I, Kudoh Y, Kishi N, Wang Y, Kubota R, Kudoh J, Kawasaki K, Minoshima S, Shimizu N (1997) Human BAC library: construction and rapid screening. Gene 191:69-79
74. Hochstrasser M (1997) Ubiquitin-dependent protein degradation. Annu Rev Genet 30:405-439
75. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425-479
76. Lovering R, Hanson IM, Borden KLB, Martin BS, O'Reilly NJ, Evan GI, Rahman D, Pappin DJC, Trowsdale J, Freemont PS (1993) Identification and preliminary characterization of a protein motif related to the zinc finger. Proc Natl Acad Sci U S A 90:2112-2116
77. Saurin AJ, Borden KLB, Boddy MN, Freemont PS (1996) Does this have a familiar RING? Trends Biochem Sci 21:208-214
78. Asaland R, Gibson TJ, Stewart AF (1996) The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci 20:56-59
79. Koenig M, Monaco AP, Kunkel LM (1998) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53:219-226
80. Kitada T, Asakawa S, Matsumine H, Hattori N, Minoshima S, Shimizu N, Mizuno Y (2000) Positional cloning of the autosomal recessive juvenile parkinsonism (AR-JP) gene and its diversity in deletion mutations. Parkinsonism Relat Disord (in press)
81. Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H, Kobayashi T, Yokochi M, Wang M, Yoritaka A, Kondo T, Kuzuhara S, Nakamura S, Shimizu N, Mizuno Y (1998) Molecular genetic analysis of a novel parkin gene in Japanese families with AR-JP: evidence for variable homozygous deletions in the parkin gene in affected individuals. Ann Neurol 44:935-941
82. Hattori N, Matsumine H, Asakawa S, Kitada T, Yoshino H, Elibol B, Brookes AJ, Yamamura Y, Kobayashi T, Wang M, Yoritaka A, Minoshima S, Shimizu N, Mizuno Y (1998) Point mutations (Thr240Arg and Gln311Stop) in parkin gene. Biochem Biophys Res Commun 249:754-758
83. Jone AC, Yamamura Y, Almasy L, Bohlega S, Elibol B, Hubble J, Kuzuhara S, Uchida M, Yanagi T, Weeks DE, Nygaard TG (1998) Autosomal recessive juvenile parkinsonism maps to 6q25.2-q27 in four ethnic groups: detailed genetic mapping of the linked region. Am J Hum Genet 63:80-87
84. Tassin J, Durr A, De Broucker T, Abbas N, Bonifati V, De Michele G, Bonnet AM, Broussolle E, Pollak P, Vidailhet M, De Mari M, Marconi R, Medjbeur S, Filla A, Meco G, Agid Y, Brice A (1998) Chromosome 6-linked autosomal recessive early-onset parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's disease genetics study group. The European consortium on genetic susceptibility in Parkinson's disease. Am J Hum Genet 63:88-94
85. Leroy E, Anastasopoulos D, Konitsiotis S, Lavedan C. Polymeropoulos MH (1998) Deletions in the parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease. Hum Genet 103:424-427
86. Lucking CB, Abbas N, Durr A, Bonifati V, Bonnet A-M, De Broucker T, De Michele G, Wood NW, Agid Y, Brice A (1998) Homozygous deletion in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European consortium on genetic susceptibility in Parkinson's disease and the French Parkinson's disease genetics study group. Lancet 352:1355-1356
87. Abbas N, Lucking CB, Ricard S, Durr A, Bonifati V, De Michele G, Bouley S, Vaughan JR, Gasser T, Marconi R, Broussolle E, Brefel-Courbon C, Harhangi BS, Oostra BA, Fabrizio E, Bohme GA, Pradier L, Wood NW, Filla A, Meco G, Denefle P, Agid Y, Brice A (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. The French Parkinson's disease genetics study group and the European consortium on genetic susceptibility in Parkinson's disease. Hum Mol Genet 8:567-574
88. Shimura H, Hattori N, Kubo Shin-ichiro, Yoshikawa M, Kitada T, Matsumine H, Asakawa S, Minoshima S, Yamamura Y, Shimizu N, Mizuno Y (1999) Immunohistochemical and subcellular localization of Parkin protein; absence of protein in autosomal recessive juvenile parkinsonism patients. Ann Neurol 45:668-672
89. Love S, Saitoh T, Quijada S, Cole GM, Terry RD (1998) Alz-50, ubiquitin, and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 47:393-405
90. Kato S, Hirano A, Llena JF (1992) Immunohistochemical, ultrastructural and immunoelectron microscopic studies of spinal cord neurofibrillary tangles in progressive supranuclear palsy. Neuropathol Appl Neurobiol 18:531-538
91. Iwatsubo T, Yamaguchi H, Fujimuro M, Yokosawa H, Ihara Y, Trojanowski JQ, Lee VM (1996) Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 148:1517-1529
92. Finley D, Bartel B, Varshavsky A (1989) The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Nature 338:394-401
93. Davletov B, Sontag JM, Hata Y, Petrenko AG, Fykse EM, Jahn R, Sudhof TC (1993) Phosphorylation of synaptotagmin I by casein kinase II. J Biol Chem 268:6816-6822
94. Apel ED, Litchfield DW, Clark RH, Krebs EG, Storm DR (1991) Phosphorylation of neuromodulin (GAP-43) by casein kinase II. Identification of phosphorylation sites and regulation by calmodulin. J Biol Chem 266:10544-10551
95. Kohtz DS, Puszkin S (1989) Phosphorylation of tubulin by casein kinase II regulates its binding to a neuronal protein (NP 185) associated with brain coated vesicles. J Neurochem 52:285-295
96. Waters CH, Miller CA (1994) Autosomal-dominant Lewy body parkinsonism in a four-generation families. Ann Neurol 35:59-64
97. Golbe LI, Lazzarini AM, Schwarz KO, Mark MH, Dickson DW, Duvoisin RC (1994) Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology. Neurology 43:2222-2227
98. Bhatia KP, Daniel SE, Marsden CD (1993) Familial parkinsonism with depression: a clinicopathological study. Ann Neurol 34:842-847
99. Perry TL, Wright JM, Berry K, Hansen S, Perry TL Jr (1996) Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome: clinical, biochemical, and neuropathologic studies of new cases. Neurology 40:1882-1887
100. Inose T, Miyakawa M, Miyakawa K, Mizushima S, Oyanagi S, Ando S (1988) Clinical and neuropathological study of a familial case of juvenile parkinsonism. Jpn J Psychiatry Neurol 42:265-276
101. Markopoulou K, Wszolek ZK, Pfeiffer RF (1995) A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 38:373-378
102. Morrison PJ, Dogwin-Austin RB, Raeburn JA (1996) Familial autosomal dominant dopa responsive Parkinson's disease in three living generations showing extreme anticipation and childhood onset. J Med Genet 33:504-506
103. Dobyns WD, Ozelius LJ, Kramer PL, Brashear A, Farlow MR, Perry TR, Walsh LE, Kasarskis EJ, Butler IJ, Breakfield XO (1993) Rapid-onset dystonia-parkinsonism. Neurology 43:2596-2602
104. Brashear A, Farlow MR, Butler IJ, Kasarskis EJ, Dobyns WB (1996) Variable phenotype of rapid-onset dystonia-parkinsonism. Mov Disord 11:151-156
105. Dwork AJ, Balmaceda C, Fazzini EA, MacCollin M, Cote L, Fahn S (1993) Dominantly inherited, early-onset parkinsonism: neuropathology of a new form. Neurology 43:69-74
106. Nukada H, Kowa H, Saito T, Tasaki Y, Miura S (1978) A big family of paralysis agitans. Rinsho Shinkeigaku 18:627-634